Baluchnejadmojarad, Tourandokht <br/><br/>
The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.  [electronic resource] 

 -  Experimental gerontology  12 2017 
 - 70-76 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-6815 
<br/><br/><label>Standard No.: </label>10.1016/j.exger.2017.10.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--genetics<br/>Brain--pathology<br/>Calcium-Calmodulin-Dependent Protein Kinase Type 2--metabolism<br/>Corpus Striatum--metabolism<br/>Cyclic AMP Response Element-Binding Protein--metabolism<br/>Cyclic AMP-Dependent Protein Kinases--metabolism<br/>Disease Models, Animal<br/>Dopaminergic Neurons--drug effects<br/>Glucuronidase--pharmacology<br/>Klotho Proteins<br/>Male<br/>Neuroprotective Agents--pharmacology<br/>Oxidative Stress--drug effects<br/>Oxidopamine<br/>Parkinson Disease--drug therapy<br/>Rats<br/>Rats, Wistar<br/>Reactive Oxygen Species--metabolism<br/>Signal Transduction--drug effects<br/>Substantia Nigra--drug effects<br/>Tyrosine 3-Monooxygenase--metabolism